Clinical Trial Update: Extended Evaluation of Deferasirox Film-coated Tablet (FCT) Formulation [Phase 3]

View source ↗

Summary

Phase 3 trial update on extended evaluation of deferasirox film-coated tablet formulation for chronic iron overload; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload

Drugs mentioned

• Deferasirox Film-coated Tablet (deferasirox)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Iron Overload | Phase 3 | Status: COMPLETED | Results posted: 2020-03-03